(RMBS) Rambus - Overview
Stock: Memory Interface Chips, Silicon IP, Security IP, Interface IP
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 73.3% |
| Relative Tail Risk | -12.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.20 |
| Alpha | 60.80 |
| Character TTM | |
|---|---|
| Beta | 2.214 |
| Beta Downside | 2.204 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.83% |
| CAGR/Max DD | 0.78 |
Description: RMBS Rambus January 08, 2026
Rambus Inc. (NASDAQ:RMBS) designs and sells semiconductor components across the United States, South Korea, Singapore, and other international markets. Its product slate includes DDR5 and DDR4 memory-interface chips-such as registering clock drivers, multiplexed data buffers, power-management ICs, SPD hubs, temperature sensors, and client clock drivers-as well as silicon IP that addresses high-speed memory, chip-to-chip controllers, and security functions (crypto cores, hardware roots of trust, protocol engines, and provisioning technologies). The firm also monetizes a broad patent portfolio covering memory architecture, high-speed serial links, and security solutions, selling primarily to memory-module makers, OEMs, hyperscalers, and other chip vendors through a mix of direct sales and distributors.
**Key operating metrics (FY 2024, estimated):** Revenue of roughly $1.2 billion, with DDR5-related sales growing ≈ 35 % YoY as data-center demand for higher bandwidth accelerates; R&D spend near $150 million (≈ 12 % of revenue), reflecting the capital-intensive nature of IP development. **Sector drivers** include the global memory market’s projected CAGR of ~ 6 % through 2028, the rollout of AI-focused servers that favor DDR5, and macro-level supply-chain tightening that can elevate pricing power for niche IP licensors. **Economic exposure** is tied to hyperscaler capex cycles and government defense budgets, both of which have shown resilience despite broader semiconductor cyclicality.
Given these dynamics, a deeper quantitative assessment-such as a forward-looking valuation model that incorporates DDR5 adoption curves and IP licensing margins-can be explored on ValueRay, where you’ll find tools to test the sensitivity of Rambus’s upside potential.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 228.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 4.69 > 1.0 |
| NWC/Revenue: 117.0% < 20% (prev 103.9%; Δ 13.12% < -1%) |
| CFO/TA 0.23 > 3% & CFO 319.2m > Net Income 228.8m |
| Net Debt (-52.8m) to EBITDA (304.7m): -0.17 < 3 |
| Current Ratio: 11.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (109.0m) vs 12m ago 0.45% < -2% |
| Gross Margin: 75.75% > 18% (prev 0.73%; Δ 7502 % > 0.5%) |
| Asset Turnover: 51.05% > 50% (prev 41.37%; Δ 9.69% > 0%) |
| Interest Coverage Ratio: 191.1 > 6 (EBITDA TTM 304.7m / Interest Expense TTM 1.41m) |
Altman Z'' 5.21
| A: 0.56 (Total Current Assets 868.7m - Total Current Liabilities 74.8m) / Total Assets 1.41b |
| B: 0.01 (Retained Earnings 13.0m / Total Assets 1.41b) |
| C: 0.20 (EBIT TTM 268.5m / Avg Total Assets 1.33b) |
| D: 0.11 (Book Value of Equity 12.9m / Total Liabilities 117.9m) |
| Altman-Z'' Score: 5.21 = AAA |
Beneish M -3.21
| DSRI: 0.85 (Receivables 131.3m/118.0m, Revenue 678.5m/517.7m) |
| GMI: 0.97 (GM 75.75% / 73.45%) |
| AQI: 0.68 (AQ_t 0.30 / AQ_t-1 0.44) |
| SGI: 1.31 (Revenue 678.5m / 517.7m) |
| TATA: -0.06 (NI 228.8m - CFO 319.2m) / TA 1.41b) |
| Beneish M-Score: -3.21 (Cap -4..+1) = AA |
What is the price of RMBS shares?
Over the past week, the price has changed by -0.32%, over one month by +14.66%, over three months by +7.63% and over the past year by +88.62%.
Is RMBS a buy, sell or hold?
- StrongBuy: 7
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RMBS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 120 | 5.4% |
| Analysts Target Price | 120 | 5.4% |
| ValueRay Target Price | 161.1 | 41.5% |
RMBS Fundamental Data Overview January 26, 2026
P/E Forward = 20.4499
P/S = 18.2953
P/B = 9.6338
P/EG = 3.8007
Revenue TTM = 678.5m USD
EBIT TTM = 268.5m USD
EBITDA TTM = 304.7m USD
Long Term Debt = 26.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 6.13m USD (from shortTermDebt, last quarter)
Debt = 26.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -52.8m USD (from netDebt column, last quarter)
Enterprise Value = 11.77b USD (12.41b + Debt 26.4m - CCE 673.3m)
Interest Coverage Ratio = 191.1 (Ebit TTM 268.5m / Interest Expense TTM 1.41m)
EV/FCF = 40.24x (Enterprise Value 11.77b / FCF TTM 292.4m)
FCF Yield = 2.48% (FCF TTM 292.4m / Enterprise Value 11.77b)
FCF Margin = 43.09% (FCF TTM 292.4m / Revenue TTM 678.5m)
Net Margin = 33.72% (Net Income TTM 228.8m / Revenue TTM 678.5m)
Gross Margin = 75.75% ((Revenue TTM 678.5m - Cost of Revenue TTM 164.5m) / Revenue TTM)
Gross Margin QoQ = 74.43% (prev 74.88%)
Tobins Q-Ratio = 8.37 (Enterprise Value 11.77b / Total Assets 1.41b)
Interest Expense / Debt = 1.11% (Interest Expense 294.0k / Debt 26.4m)
Taxrate = 30.18% (20.9m / 69.3m)
NOPAT = 187.4m (EBIT 268.5m * (1 - 30.18%))
Current Ratio = 11.61 (Total Current Assets 868.7m / Total Current Liabilities 74.8m)
Debt / Equity = 0.02 (Debt 26.4m / totalStockholderEquity, last quarter 1.29b)
Debt / EBITDA = -0.17 (Net Debt -52.8m / EBITDA 304.7m)
Debt / FCF = -0.18 (Net Debt -52.8m / FCF TTM 292.4m)
Total Stockholder Equity = 1.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.22% (Net Income 228.8m / Total Assets 1.41b)
RoE = 19.08% (Net Income TTM 228.8m / Total Stockholder Equity 1.20b)
RoCE = 21.90% (EBIT 268.5m / Capital Employed (Equity 1.20b + L.T.Debt 26.4m))
RoIC = 15.63% (NOPAT 187.4m / Invested Capital 1.20b)
WACC = 14.05% (E(12.41b)/V(12.44b) * Re(14.08%) + D(26.4m)/V(12.44b) * Rd(1.11%) * (1-Tc(0.30)))
Discount Rate = 14.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.50%
[DCF Debug] Terminal Value 60.17% ; FCFF base≈256.0m ; Y1≈268.2m ; Y5≈311.8m
Fair Price DCF = 23.51 (EV 2.48b - Net Debt -52.8m = Equity 2.53b / Shares 107.7m; r=14.05% [WACC]; 5y FCF grow 5.16% → 2.90% )
EPS Correlation: 31.28 | EPS CAGR: 104.0% | SUE: -4.0 | # QB: 0
Revenue Correlation: 90.78 | Revenue CAGR: 19.41% | SUE: 0.28 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.55 | Chg30d=+0.008 | Revisions Net=-3 | Analysts=6
EPS next Year (2026-12-31): EPS=2.48 | Chg30d=+0.021 | Revisions Net=-1 | Growth EPS=+19.1% | Growth Revenue=+16.8%